The assessment of global TCR complexity revealed that DTA-1 treatment in case of dLN increased overall diversity of both Tregs and CD4+Teffs, but in the tumor, only diversity of Tregs—mainly those of low abundance—increased, while the diversity of Teffs decreased (Fig. 4b). The gene discussed is CD4; the disease is neoplasm.